Terms: = Gastric cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Prognosis
139 results:
1. LncRNA SNHG26 promotes gastric cancer progression and metastasis by inducing c-myc protein translation and an energy metabolism positive feedback loop.
Wu ZH; Wang YX; Song JJ; Zhao LQ; Zhai YJ; Liu YF; Guo WJ
Cell Death Dis; 2024 Mar; 15(3):236. PubMed ID: 38553452
[TBL] [Abstract] [Full Text] [Related]
2. [Overexpression of BZW1 promotes invasion and metastasis of gastric cancer cells by regulating Wnt/β-catenin signaling and promoting epithelial-mesenchymal transition].
Zhang W; Zhang N; Yang Z; Zhang X; Sun A; Wang L; Song X; Geng Z; Li J; Hu J
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Feb; 44(2):354-362. PubMed ID: 38501421
[TBL] [Abstract] [Full Text] [Related]
3. RAE1 promotes gastric carcinogenesis and epithelial-mesenchymal transition.
Dong W; Li X; Cheng L; Yang J; Zhao Z; Qiang X; Li P; Wu J; Guo L
Arch Biochem Biophys; 2024 Apr; 754():109896. PubMed ID: 38417691
[TBL] [Abstract] [Full Text] [Related]
4. Profiling Kinase Activities for Precision Oncology in Diffuse gastric cancer.
Singh S; Parthasarathi KTS; Bhat MY; Gopal C; Sharma J; Pandey A
OMICS; 2024 Feb; 28(2):76-89. PubMed ID: 38271566
[TBL] [Abstract] [Full Text] [Related]
5. Multi-dimension metabolic prognostic model for gastric cancer.
Feng W; Xu B; Zhu X
Front Endocrinol (Lausanne); 2023; 14():1228136. PubMed ID: 38144563
[TBL] [Abstract] [Full Text] [Related]
6. Tumor suppressive function of IGF2BP1 in gastric cancer through decreasing myc.
Ding N; Cao G; Wang Z; Xu S; Chen W
Cancer Sci; 2024 Feb; 115(2):427-438. PubMed ID: 38115228
[TBL] [Abstract] [Full Text] [Related]
7. FTO up-regulation induced by myc suppresses tumour progression in Epstein-Barr virus-associated gastric cancer.
Xu YY; Li T; Shen A; Bao XQ; Lin JF; Guo LZ; Meng Q; Ruan DY; Zhang QH; Zuo ZX; Zeng ZL
Clin Transl Med; 2023 Dec; 13(12):e1505. PubMed ID: 38082402
[TBL] [Abstract] [Full Text] [Related]
8. The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression.
Jing X; Luo Z; Wu J; Ye F; Li J; Song Z; Zhang Y; Shi M; Sun H; Fang Y; Jiang Y; Ji X
Cancer Med; 2023 Dec; 12(24):21905-21919. PubMed ID: 38050871
[TBL] [Abstract] [Full Text] [Related]
9. Setd2 deficiency promotes gastric tumorigenesis through inhibiting the SIRT1/FOXO pathway.
Feng W; Ma C; Rao H; Zhang W; Liu C; Xu Y; Aji R; Wang Z; Xu J; Gao WQ; Li L
Cancer Lett; 2023 Nov; 579():216470. PubMed ID: 37914019
[TBL] [Abstract] [Full Text] [Related]
10. Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis.
Zhang XD; Liu ZY; Luo K; Wang XK; Wang MS; Huang S; Li RF
Sci Rep; 2023 Oct; 13(1):16859. PubMed ID: 37803063
[TBL] [Abstract] [Full Text] [Related]
11. Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma.
Liang PI; Lai HY; Chan TC; Li WM; Hsing CH; Huang SK; Hsieh KL; Tseng WH; Chen TJ; Li WS; Chen HD; Kuo YH; Li CF
BMC Cancer; 2023 Jun; 23(1):599. PubMed ID: 37380971
[TBL] [Abstract] [Full Text] [Related]
12. Oncogenic Impact of TONSL, a Homologous Recombination Repair Protein at the Replication Fork, in cancer Stem Cells.
Lee H; Ha S; Choi S; Do S; Yoon S; Kim YK; Kim WY
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298484
[TBL] [Abstract] [Full Text] [Related]
13. Downregulated KDM6A mediates gastric carcinogenesis via Wnt/β-catenin signaling pathway mediated epithelial-to-mesenchymal transition.
Feng Z; Ding H; Peng Z; Hu K
Pathol Res Pract; 2023 May; 245():154461. PubMed ID: 37060821
[TBL] [Abstract] [Full Text] [Related]
14. Dual inhibition of myc and SLC39A10 by a novel natural product STAT3 inhibitor derived from Chaetomium globosum suppresses tumor growth and metastasis in gastric cancer.
Guan X; Yang J; Wang W; Zhao B; Hu S; Yu D; Yuan L; Shi Y; Xu J; Dong J; Wang J; Cheng XD; Qin JJ
Pharmacol Res; 2023 Mar; 189():106703. PubMed ID: 36804016
[TBL] [Abstract] [Full Text] [Related]
15. LncRNA DIRC1 is a novel prognostic biomarker and correlated with immune infiltrates in stomach adenocarcinoma.
Lin Y; Zhang Z; Li Y; Chen Y; Su M; Zhao W
Medicine (Baltimore); 2022 Nov; 101(46):e31839. PubMed ID: 36401393
[TBL] [Abstract] [Full Text] [Related]
16. gastric cancer-derived mesenchymal stem cells promote gastric cancer cell lines migration by modulating CD276 expression.
Gao Q; Cui L; Huang C; Chen Z; Wang X; Wen S; Zhao Y; Wang M; Shen B; Zhu W
Exp Cell Res; 2023 Jan; 422(1):113414. PubMed ID: 36368567
[TBL] [Abstract] [Full Text] [Related]
17. Overexpression of Bromodomain and Extraterminal Domain is Associated with Progression, Metastasis and Unfavorable Outcomes: Highlighting Prognostic and Therapeutic Value of the BET Protein Family in gastric cancer.
Fard SS; Kouchaki S; Salimian Z; Sotoudeh M; Mousavi SA; Alimoghaddam K; Ghaffari SH
Anticancer Agents Med Chem; 2023; 23(7):794-806. PubMed ID: 36284375
[TBL] [Abstract] [Full Text] [Related]
18. HOXC10 indicates poor survival outcome in gastric cancer and promotes G1/S cell cycle transition through transcriptional repression of p21.
Lin ZH; He JM; Lai SC; Ding N; Jiang Y; He XK; Liu XS; Huang ZH
Neoplasma; 2022 Dec; 69(6):1303-1313. PubMed ID: 36264773
[TBL] [Abstract] [Full Text] [Related]
19. Expression of
Chung MW; Park YL; Park SY; Joo YE
In Vivo; 2022; 36(5):2194-2204. PubMed ID: 36099146
[TBL] [Abstract] [Full Text] [Related]
20. Biomarker Profiling Revealed Carcinoembryonic Antigen as a Target of Artesunate in a Ductal Breast cancer Patient.
Saeed MEM; Drif AI; Efferth T
Anticancer Res; 2022 Jul; 42(7):3483-3494. PubMed ID: 35790273
[TBL] [Abstract] [Full Text] [Related]
[Next]
